BONALDI, LORENA
BONALDI, LORENA
Istituto di Bioimmagini e Fisiologia Molecolare - IBFM
A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset.
2008 Panzacchi, A; Moresco, Rm; Garibotto, V; Antonini, A; Gobbo, C; Isaias, Iu; Goldwurm, S; Bonaldi, L; Carpinelli, A; Pezzoli, G; Fazio, F; Perani, D
Fluvoxamine treatment and D(2) receptors: a PET study on OCD drug-naive patients
2007 Moresco R.M. ;; Pietra L. ; Henin M. ; Panzacchi A .; Locatelli M. ; Bonaldi L. ; Carpinelli A. ;; Gobbo C. ; Bellodi L. ; Perani D. ; Fazio F. ;
Dopamine D2 receptors in drug naive obsessive compulsive patients: Effect of fluvoxamine assessed by PET and [11C]Raclopride
2004 Panzacchi, A; Moresco, Rm; Pietra, L; Locatelli, A; Perani, D; Bonaldi, L; Matarrese, M; Gobbo, C; Belloli, S; Bellodi, L; Fazio, F
Effect of fluvoxamine on cortical 5HT2A receptors assessed dy PET and (11C) MDL100907 in drug naive obsessive compulsive patients
2002 Moresco, Rm; Locatelli, M; Perani, D; Gobbo, C; Panzacchi, A; Rizzo, G; Henin, M; Matarrese, M; Bonaldi, L; Bellodi, L; Fazio, F
Progression of Parkinson's disease in patients with early and late onset disease: a PET study with [11C]Fe-CIT
2002 Gobbo, C; Moresco, Rm; Panzacchi, A; Antonini, A; Lucignani, G; Bonaldi, L; Quilici, L; Matarrese, M; Carpinelli, A; Fazio, F
The feasibility of statistical parametric mapping for the analysis of positron emission tomography studies using 11C-2-beta-carbomethoxy-3-beta-(4-fluorophenyl)-tropane in patients with movement disorders
2002 Lucignani, G; Gobbo, C; Moresco, Rm; Antonini, A; Panzacchi, A; Bonaldi, L; Carpinelli, A; Caraceni, T; Fazio, F
Validation of SPM for the automatic analysis of [11C]FE-CIT: PET images in patients with movement disorders.
2002 Gobbo C.; Panzacchi A.; Lucignani G.; Moresco R.M.; Antonini A.; Bonaldi L.; Quilici L.; Carpinelli A.; Fazio F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A voxel-based PET study of dopamine transporters in Parkinson's disease: relevance of age at onset. | 1-gen-2008 | Panzacchi, A; Moresco, Rm; Garibotto, V; Antonini, A; Gobbo, C; Isaias, Iu; Goldwurm, S; Bonaldi, L; Carpinelli, A; Pezzoli, G; Fazio, F; Perani, D | |
| Fluvoxamine treatment and D(2) receptors: a PET study on OCD drug-naive patients | 1-gen-2007 | Moresco R.M. ;; Pietra L. ; Henin M. ; Panzacchi A .; Locatelli M. ; Bonaldi L. ; Carpinelli A. ;; Gobbo C. ; Bellodi L. ; Perani D. ; Fazio F. ; | |
| Dopamine D2 receptors in drug naive obsessive compulsive patients: Effect of fluvoxamine assessed by PET and [11C]Raclopride | 1-gen-2004 | Panzacchi, A; Moresco, Rm; Pietra, L; Locatelli, A; Perani, D; Bonaldi, L; Matarrese, M; Gobbo, C; Belloli, S; Bellodi, L; Fazio, F | |
| Effect of fluvoxamine on cortical 5HT2A receptors assessed dy PET and (11C) MDL100907 in drug naive obsessive compulsive patients | 1-gen-2002 | Moresco, Rm; Locatelli, M; Perani, D; Gobbo, C; Panzacchi, A; Rizzo, G; Henin, M; Matarrese, M; Bonaldi, L; Bellodi, L; Fazio, F | |
| Progression of Parkinson's disease in patients with early and late onset disease: a PET study with [11C]Fe-CIT | 1-gen-2002 | Gobbo, C; Moresco, Rm; Panzacchi, A; Antonini, A; Lucignani, G; Bonaldi, L; Quilici, L; Matarrese, M; Carpinelli, A; Fazio, F | |
| The feasibility of statistical parametric mapping for the analysis of positron emission tomography studies using 11C-2-beta-carbomethoxy-3-beta-(4-fluorophenyl)-tropane in patients with movement disorders | 1-gen-2002 | Lucignani, G; Gobbo, C; Moresco, Rm; Antonini, A; Panzacchi, A; Bonaldi, L; Carpinelli, A; Caraceni, T; Fazio, F | |
| Validation of SPM for the automatic analysis of [11C]FE-CIT: PET images in patients with movement disorders. | 1-gen-2002 | Gobbo C.; Panzacchi A.; Lucignani G.; Moresco R.M.; Antonini A.; Bonaldi L.; Quilici L.; Carpinelli A.; Fazio F. |